Zobrazeno 1 - 10
of 1 000
pro vyhledávání: '"bone-targeting"'
Autor:
Briffault E, Reyes R, Garcia-Garcia P, Rouco H, Diaz-Gomez L, Arnau MR, Evora C, Diaz-Rodriguez P, Delgado A
Publikováno v:
International Journal of Nanomedicine, Vol Volume 19, Pp 12171-12188 (2024)
Erik Briffault,1,2 Ricardo Reyes,2,3 Patricia Garcia-Garcia,1,2 Helena Rouco,1 Luis Diaz-Gomez,4 Maria Rosa Arnau,2,5 Carmen Evora,1,3 Patricia Diaz-Rodriguez,2,4 Araceli Delgado1,2 1Department of Chemical Engineering and Pharmaceutical Technology, U
Externí odkaz:
https://doaj.org/article/ba8968a6faa6491cab2a32bf85971956
Publikováno v:
International Journal of Nanomedicine, Vol Volume 19, Pp 7983-7996 (2024)
Demeng Xia,1,2,* Qingqing Qian,1,* Sheng Wang,3,* Xiao Dong,4 Ying Liu5 1Department of Pharmacy, The Fifth People’s Hospital of Shanghai, Fudan University, Shanghai, 200240, People’s Republic of China; 2Department of Pharmacy, Seventh
Externí odkaz:
https://doaj.org/article/f4f1dc7bab47405a9e6919f6cdddea87
Autor:
Zhenzhen Weng, Jing Ye, Changxiong Cai, Zikang Liu, Yuanyuan Liu, Yingying Xu, Jinghong Yuan, Wei Zhang, Lubing Liu, Junkai Jiang, Xigao Cheng, Xiaolei Wang
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-17 (2024)
Abstract Osteoporosis is the most common bone metabolic disease that affects the health of middle-aged and elderly people, which is hallmarked by imbalanced bone remodeling and a deteriorating immune microenvironment. Magnesium and calcium are pivota
Externí odkaz:
https://doaj.org/article/576ecb18a7794666bbda52e11b11ce57
Autor:
Qing Zhao, Junjie Feng, Fubin Liu, Qianxin Liang, Manlin Xie, Jiaming Dong, Yanfang Zou, Jiali Ye, Guilong Liu, Yue Cao, Zhaodi Guo, Hongzhi Qiao, Lei Zheng, Kewei Zhao
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 14, Iss 5, Pp 2210-2227 (2024)
Although various anti-osteoporosis drugs are available, the limitations of these therapies, including drug resistance and collateral responses, require the development of novel anti-osteoporosis agents. Rhizoma Drynariae displays a promising anti-ost
Externí odkaz:
https://doaj.org/article/18a0acbe3c9445bba0ac9c444acf0a4c
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-18 (2024)
Abstract Osteoporosis is a highly prevalent metabolic disease characterized by low systemic bone mass and deterioration of bone microarchitecture, resulting in reduced bone strength and increased fracture risk. Current treatment options for osteoporo
Externí odkaz:
https://doaj.org/article/48fc6aa98ee44576960e20155fa290df
Autor:
Michael Mark, Alfonso Rojas Mora, Thomas Winder, Anastasios Stathis, Andreas Jakob, Gisela Müller, Stefanie Hayoz, Patrick Reimann, Ulf Petrausch, Roger von Moos
Publikováno v:
Bone Reports, Vol 22, Iss , Pp 101794- (2024)
Background: Patients with bone metastases from solid tumors often have additional treatment with bone targeted agents (BTAs) to avoid symptomatic skeletal events (SSEs) such as clinically significant pathological fracture leading toradiation therapy
Externí odkaz:
https://doaj.org/article/c371b8c746ab4e2dabf3b1a2c7b4966c
Publikováno v:
International Journal of Nanomedicine, Vol Volume 19, Pp 1363-1383 (2024)
Caining Wen,1,* Xiao Xu,1,* Yuanmin Zhang,1 Jiang Xia,2 Yujie Liang,1,3 Limei Xu1 1Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, People’s Republic of China; 2Department of Chemistry, the Chin
Externí odkaz:
https://doaj.org/article/c5cd3b93c4f249fba44aeb4a13206aa3
Publikováno v:
International Journal of Nanomedicine, Vol Volume 19, Pp 471-488 (2024)
Linyuan Gui,1,* Qingyuan Ye,2,* Lu Yu,3 Geng Dou,1 Yang Zhou,1 Yang Liu,4 Yanqi Zhang,5 Xiaoshan Yang,1,6 Fang Jin,5 Shiyu Liu,1 Yan Jin,1 Lili Ren1 1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clini
Externí odkaz:
https://doaj.org/article/51ab03d4df514c21936d6384116fec84
Autor:
Han Liu, Peiran Song, Hao Zhang, Fengjin Zhou, Ning Ji, Mingkai Wang, Guangyin Zhou, Ruina Han, Xinru Liu, Weizong Weng, Haoqi Tan, Sicheng Wang, Lei Zheng, Yingying Jing, Jiacan Su
Publikováno v:
Journal of Extracellular Vesicles, Vol 13, Iss 4, Pp n/a-n/a (2024)
Abstract Osteoporosis (OP) is a systematic bone disease characterized by low bone mass and fragile bone microarchitecture. Conventional treatment for OP has limited efficacy and long‐term toxicity. Synthetic biology makes bacterial extracellular ve
Externí odkaz:
https://doaj.org/article/0b9e503941bd4feb81eac0174242cfbc
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 9, Iss 1, Pp 1-13 (2023)
Abstract Background Osteoporosis, among other bone diseases, has become a prevalent cause of decreased quality of life in older and postmenopausal women. Traditional anti-osteoporotic therapies, though widely prescribed, are limited by a lack of cell
Externí odkaz:
https://doaj.org/article/0cc2ba1119114886a77a1f3190780b82